CRON
Cronos Group Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Buy
+32/100
Last price
3.29
▲ 0.04 (1.08%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
3.25
Day high
3.30
Day low
3.24
Volume
677.77K
Market cap
$1.21B
P/E (TTM)
17.29
52W range
2.28 – 3.61
Trailing performance
Returnvs SPY
1W
-2.81%
-4.8%
1M
+0.77%
-0.4%
3M
+19.45%
+14.9%
6M
+30.36%
+12.2%
YTD
+24.90%
+10.7%
1Y
+27.33%
+10.9%
3Y
+64.25%
-18.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on CRON open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
181.04M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 12, 26 | Buggy (Shannon) Senior Officer of Issuer |
— | 20.62K | — | Direct |
| May 12, 26 | Buggy (Shannon) Senior Officer of Issuer |
EXERCISE | 9.18K | $25.24K | Direct |
| May 12, 26 | Doucet (Terrence Gregory Joseph) Senior Officer of Issuer |
— | 10.60K | — | Direct |
| May 12, 26 | Doucet (Terrence Gregory Joseph) Senior Officer of Issuer |
EXERCISE | 5.20K | $14.24K | Direct |
| May 12, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
— | 9.41K | — | Direct |
| May 12, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
EXERCISE | 3.70K | $10.18K | Direct |
| May 12, 26 | Wagner (Adam Shmuel) Senior Officer of Issuer |
— | 10.37K | — | Direct |
| May 10, 26 | Wagner (Adam Shmuel) Senior Officer of Issuer |
— | 10.06K | — | Direct |
| May 10, 26 | Wagner (Adam Shmuel) Senior Officer of Issuer |
— | 10.41K | — | Direct |
| May 10, 26 | Weigensberg (Aaron Arye) Senior Officer of Issuer |
— | 3.12K | — | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
— | 7.54K | — | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
EXERCISE | 2.90K | $7.36K | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
— | 5.11K | — | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
EXERCISE | 1.88K | $4.77K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Buggy (Shannon) |
Senior Officer of Issuer | 187.50K | Grant of options |
Doucet (Terrence Gregory Joseph) |
Senior Officer of Issuer | 115.79K | Grant of options |
Gorenstein (Michael Ryan) |
Director of Issuer | 13.34M | Grant of options |
Jacobson (Jeffrey David) |
Senior Officer of Issuer | 507.23K | Grant of options |
Kenost (Jared Matthew) |
Senior Officer of Issuer | 46.67K | Grant of options |
Shlimak (Anna) |
Senior Officer of Issuer | 368.36K | Grant of options |
Wagner (Adam Shmuel) |
Senior Officer of Issuer | 103.99K | Grant of options |
Weigensberg (Aaron Arye) |
Senior Officer of Issuer | 211.56K | Grant of options |
Fundamentals
Market cap$1.21B
Enterprise value$463.29M
Revenue (TTM)$179.09M
Gross profit$77.04M
EBITDA$11.88M
Net income$69.98M
EPS (TTM)$0.19
Free cash flow$6.11M
Total cash$797.02M
Total debt$1.29M
Book value / share$2.88
Shares outstanding368.41M
Float186.99M
Short % of float1.78%
Dividend yield0.00%
Beta (5Y)1.20
Valuation & profitability ratios
Trailing P/E17.29
Forward P/E-82.13
PEG ratio—
Price / sales—
Price / book1.14
EV / revenue2.59
EV / EBITDA39.00
Gross margin43.02%
Operating margin15.44%
Profit margin39.08%
Return on equity7.05%
Return on assets-0.10%
Debt / equity0.12
Current ratio16.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $146.59M | $117.61M | $87.24M | $86.75M | +24.6% |
| Operating revenue | $193.36M | $161.82M | $120.27M | $109.30M | +19.5% |
| Cost of revenue | $83.83M | $92.42M | $75.33M | $71.31M | -9.3% |
| Gross profit | $62.76M | $25.20M | $11.91M | $15.44M | +149.1% |
| Research & development | $4.45M | $4.23M | $5.84M | $13.13M | +5.2% |
| Selling, general & admin | $70.81M | $76.82M | $80.93M | $100.73M | -7.8% |
| Total operating expense | $82.26M | $84.75M | $91.82M | $119.83M | -2.9% |
| Operating income | -$19.50M | -$59.55M | -$79.91M | -$104.39M | +67.3% |
| Net interest income | $39.96M | $52.02M | $51.23M | $22.51M | -23.2% |
| Pre-tax income | -$17.12M | $36.59M | -$73.67M | -$121.00M | -146.8% |
| Tax provision | -$14.19M | -$3.44M | -$3.23M | $34.17M | -313.0% |
| Net income | -$9.45M | $41.08M | -$73.96M | -$168.73M | -123.0% |
| Net income to common | -$9.45M | $41.08M | -$73.96M | -$168.73M | -123.0% |
| Basic EPS | -0.02 | 0.11 | -0.19 | -0.45 | -118.2% |
| Diluted EPS | -0.02 | 0.11 | -0.19 | -0.45 | -118.2% |
| EBIT | -$19.50M | -$59.55M | -$79.91M | -$104.39M | +67.3% |
| EBITDA | -$5.27M | -$50.21M | -$71.80M | -$91.27M | +89.5% |
| Basic shares | 383.47M | 382.06M | 380.96M | 376.96M | +0.4% |
| Diluted shares | 383.47M | 385.56M | 380.96M | 376.96M | -0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $791.79M | $858.80M | $669.29M | $764.64M | -7.8% |
| Cash & short-term investments | $831.79M | $858.80M | $861.53M | $877.72M | -3.1% |
| Accounts receivable | $34.10M | $15.46M | $13.98M | $23.11M | +120.5% |
| Inventory | $46.75M | $33.15M | $30.50M | $37.56M | +41.0% |
| Total current assets | $944.09M | $936.11M | $933.31M | $960.16M | +0.9% |
| Property, plant & equipment | $147.29M | $134.58M | $60.82M | $62.83M | +9.4% |
| Goodwill & intangibles | $75.37M | $74.71M | $22.14M | $27.74M | +0.9% |
| Total assets | $1.20B | $1.17B | $1.14B | $1.21B | +2.6% |
| Total current liabilities | $48.19M | $49.70M | $41.40M | $68.12M | -3.0% |
| Total debt | $1.51M | $2.02M | $2.55M | $3.88M | -25.2% |
| Total liabilities | $54.18M | $55.33M | $44.14M | $72.05M | -2.1% |
| Retained earnings | $447.76M | $457.71M | $416.72M | $490.68M | -2.2% |
| Shareholder equity | $1.09B | $1.06B | $1.10B | $1.14B | +2.8% |
| Working capital | $895.90M | $886.41M | $891.91M | $892.04M | +1.1% |
| Net tangible assets | $1.02B | $989.35M | $1.08B | $1.12B | +2.9% |
| Shares issued | 381.59M | 382.53M | 381.30M | 380.58M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$2.93M | $40.02M | -$74.55M | -$168.73M | -107.3% |
| Depreciation & amortisation | $14.23M | $9.34M | $8.11M | $13.12M | +52.4% |
| Stock-based compensation | $7.05M | $8.70M | $8.77M | $15.12M | -19.0% |
| Change in working capital | -$34.41M | -$311.00K | -$26.47M | $15.66M | -10,965.6% |
| Operating cash flow | $25.87M | $18.84M | -$42.84M | -$88.95M | +37.3% |
| Capital expenditure | -$26.06M | -$13.15M | -$3.42M | -$5.03M | -98.1% |
| Investing cash flow | -$76.56M | $175.15M | -$59.50M | -$1.84M | -143.7% |
| Share buybacks | -$9.74M | $0 | $0 | — | — |
| Financing cash flow | -$19.91M | -$1.23M | -$1.03M | -$2.90M | -1,517.0% |
| Free cash flow | -$190.00K | $5.69M | -$46.26M | -$93.98M | -103.3% |
| End cash position | $791.79M | $858.80M | $669.29M | $764.64M | -7.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $53.01M | $45.21M | $44.53M | $36.34M | $33.45M | +17.2% |
| Operating revenue | $70.60M | $58.97M | $58.38M | $48.83M | $44.25M | +19.7% |
| Cost of revenue | $24.56M | $26.06M | $28.34M | $18.01M | $18.95M | -5.8% |
| Gross profit | $28.45M | $19.15M | $16.19M | $18.33M | $14.50M | +48.5% |
| Research & development | $1.22M | $1.41M | $1.38M | $1.34M | $929.00K | -14.0% |
| Selling, general & admin | $19.14M | $18.66M | $20.70M | $16.89M | $17.26M | +2.6% |
| Total operating expense | $20.85M | $20.61M | $22.59M | $23.36M | $19.06M | +1.2% |
| Operating income | $7.60M | -$1.46M | -$6.40M | -$5.03M | -$4.56M | +622.6% |
| Net interest income | $8.82M | $8.85M | $9.56M | $11.74M | $9.00M | -0.4% |
| Pre-tax income | $35.71M | $18.14M | -$12.39M | $27.00M | -$39.01M | +96.9% |
| Tax provision | $51.00K | $2.43M | -$11.89M | -$1.32M | -$525.00K | -97.9% |
| Net income | $32.09M | $13.75M | -$1.82M | $25.96M | -$39.71M | +133.3% |
| Net income to common | $32.09M | $13.75M | -$1.82M | $25.96M | -$39.71M | +133.3% |
| Basic EPS | 0.09 | 0.04 | 0.00 | 0.07 | -0.10 | +125.0% |
| Diluted EPS | 0.09 | 0.04 | 0.00 | 0.07 | -0.10 | +125.0% |
| EBIT | $7.60M | -$1.46M | -$6.40M | -$5.03M | -$4.56M | +622.6% |
| EBITDA | $10.98M | $2.27M | -$2.74M | -$1.49M | -$354.00K | +383.2% |
| Basic shares | 373.61M | 343.80M | 382.53M | 383.09M | 385.31M | +8.7% |
| Diluted shares | 375.06M | 343.80M | 382.53M | 384.99M | 385.31M | +9.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $467.02M | $821.86M | $791.79M | $784.17M | $794.42M | -43.2% |
| Cash & short-term investments | $797.02M | $821.86M | $831.79M | $824.17M | $834.42M | -3.0% |
| Accounts receivable | $36.72M | $32.96M | $34.10M | $27.09M | $26.62M | +11.4% |
| Inventory | $52.70M | $48.68M | $46.75M | $48.17M | $42.14M | +8.3% |
| Total current assets | $912.03M | $927.88M | $944.09M | $922.15M | $927.15M | -1.7% |
| Property, plant & equipment | $142.82M | $143.41M | $147.29M | $147.06M | $151.92M | -0.4% |
| Goodwill & intangibles | $72.20M | $73.98M | $75.37M | $75.24M | $77.48M | -2.4% |
| Total assets | $1.18B | $1.17B | $1.20B | $1.18B | $1.18B | +0.7% |
| Total current liabilities | $56.36M | $42.42M | $48.19M | $41.07M | $37.61M | +32.9% |
| Total debt | $1.29M | $1.31M | $1.51M | $1.74M | $2.01M | -1.2% |
| Total liabilities | $62.41M | $48.30M | $54.18M | $46.36M | $45.02M | +29.2% |
| Retained earnings | $492.32M | $460.54M | $447.76M | $450.03M | $424.08M | +6.9% |
| Shareholder equity | $1.07B | $1.07B | $1.09B | $1.08B | $1.08B | -0.5% |
| Working capital | $855.67M | $885.46M | $895.90M | $881.08M | $889.53M | -3.4% |
| Net tangible assets | $996.48M | $999.68M | $1.02B | $1.01B | $1.00B | -0.3% |
| Shares issued | 370.73M | 376.26M | 381.59M | 382.89M | 383.81M | -1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $35.66M | $15.71M | -$491.00K | $28.32M | -$38.48M | +127.0% |
| Depreciation & amortisation | $3.37M | $3.73M | $3.66M | $3.53M | $4.20M | -9.5% |
| Stock-based compensation | $1.56M | $1.31M | $1.25M | $2.33M | $1.38M | +18.6% |
| Change in working capital | $1.73M | $276.00K | -$6.60M | -$5.79M | -$7.48M | +525.0% |
| Operating cash flow | $24.01M | $10.90M | $11.84M | $13.31M | $2.82M | +120.3% |
| Capital expenditure | -$1.78M | -$1.97M | -$2.27M | -$4.59M | -$3.84M | +9.6% |
| Investing cash flow | -$358.30M | $38.03M | $2.78M | -$23.00M | -$983.00K | -1,042.2% |
| Share buybacks | -$16.13M | -$16.73M | -$4.27M | -$1.86M | -$3.61M | +3.6% |
| Financing cash flow | -$20.88M | -$18.27M | -$7.42M | -$1.87M | -$7.69M | -14.3% |
| Free cash flow | $22.23M | $8.93M | $9.56M | $8.72M | -$1.02M | +149.0% |
| End cash position | $467.02M | $821.86M | $791.79M | $784.17M | $794.42M | -43.2% |
Options analytics
Put / call volume
0.04
Call-heavy session
Put / call open interest
0.18
Positioning, not flow
Max pain
3.00
-8.7% from spot
ATM implied vol
12.5%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
218
Contracts, this expiry
Put volume
8
Contracts, this expiry
Heaviest call OI
4.00
1.97K contracts
Heaviest put OI
3.00
455 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.01 | 0.13 | +802.1% |
| Mar 2026 | 0.01 | 0.05 | +682.3% |
| Dec 2025 | 0.02 | 0.00 | -100.0% |
| Sep 2025 | 0.00 | 0.10 | 0.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.04 | 2 | $73.39M | +42.9% |
| Next quarter | 0.04 | 2 | $85.35M | +40.1% |
| Current year | 0.22 | 3 | $294.27M | +46.7% |
| Next year | 0.18 | 2 | $363.21M | +23.4% |
Analyst targets & ownership
Mean target$2.46
High target$2.46
Low target$2.46
Implied upside-25.04%
Analyst count1
ConsensusSTRONG BUY
Strong buy / Buy0 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders49.14%
Held by institutions15.49%
Institutions holding239
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.31
-0.82% from price
SMA 20
3.29
-0.12% from price
SMA 50
3.21
+2.40% from price
SMA 100
2.98
+10.34% from price
SMA 200
2.80
+17.22% from price
EMA 12
3.29
-0.24% from price
EMA 26
3.28
+0.27% from price
EMA 50
3.19
+2.86% from price
RSI (14)
50.9
Neutral
MACD (12,26,9)
0.02
Hist -0.02
ATR (14)
0.10
2.95% of price
Realised vol 30D
31.2%
Annualised
Bollinger upper
3.46
20, 2σ
Bollinger lower
3.12
20, 2σ
50 / 200 cross
Golden
3.21 vs 2.80
Trend bias
Above 200
+17.22%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.72
Less volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
31.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-26.9%
Peak to trough
Max drawdown 5Y
-75.9%
Peak to trough
ATR 14
0.10
2.95% of price
Beta (reported)
1.20
5Y monthly, from filing
Short interest
Shares short
3.25M
Prior 3.38M
Change vs prior
-3.8%
Shorts covering
% of float
1.78%
Normal
% of shares out
0.88%
Against total outstanding
Days to cover
2.8
Liquid
Float
186.99M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 15, 24 | CIBC | MAINTAINED | Outperformer | Outperformer |
| Apr 8, 24 | B of A Securities | MAINTAINED | Underperform | Underperform |
| Dec 28, 23 | B of A Securities | MAINTAINED | Underperform | Underperform |
| May 15, 23 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Nov 2, 22 | Bernstein | INITIATED | — | Market Perform |
| Sep 30, 22 | Barclays | MAINTAINED | — | Equal-Weight |
| Mar 22, 22 | Barclays | UPGRADE | Underweight | Equal-Weight |
| Mar 7, 22 | Piper Sandler | MAINTAINED | — | Neutral |
| Feb 22, 22 | Canaccord Genuity | MAINTAINED | — | Sell |
| Feb 22, 22 | Piper Sandler | MAINTAINED | — | Neutral |
| Jan 27, 22 | Jefferies | UPGRADE | Underperform | Hold |
| Nov 18, 21 | Barclays | INITIATED | — | Underweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-11
Corporate Changes & Voting Matters
8-K/A · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-22
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Periodic Financial Reports
10-Q · 2026-05-11
Proxy Statements
DEF 14A · 2026-04-24
Corporate Changes & Voting Matters
8-K · 2026-02-26
Headlines
Is Cronos Group (TSX:CRON) A Bargain Following Its Proposed $10 Million Settlement?
Simply Wall St. · 2d ago
Can Cronos turn production and brand power into a bigger cannabis comeback?
Investing.com · 9d ago
Canadian Penny Stocks To Watch In September 2026
Simply Wall St. · 9d ago
Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions
MarketBeat · 13d ago
Cronos Hosts 2026 Investor Day
GlobeNewswire · 13d ago
Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement
CNW Group · 14d ago
3 Canadian Penny Stocks To Watch With Up To 95% Fair Value Discount
Simply Wall St. · 15d ago
2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026
Motley Fool · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.